The inter-group comparisons also showed that T2DM patients, irrespective of statin use, had significantly different levels of plasma TUDCA, GUDCA, GCA, UDCA, CA, GCDCA and CDCA, as well as different levels of plasma total and primary or secondary BAs than compared with non-diabetic subjects. This evidence concerns the gene GCA and type 2 diabetes mellitus.